Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen (AMGN) Stock Down in After-Hours Trading Despite Q2 Earnings Beat, Positive Guidance
Amgen (AMGN) Stock Down in After-Hours Trading Despite Q2 Earnings Beat, Positive Guidance
Amgen (AMGN) Stock Down in After-Hours Trading Despite Q2 Earnings Beat, Positive Guidance
Submitted by
admin
on July 27, 2016 - 6:26pm
Source:
TheStreet.com
News Tags:
Amgen
earnings
Headline:
Amgen (AMGN) Stock Down in After-Hours Trading Despite Q2 Earnings Beat, Positive Guidance
Do Not Allow Advertisers to Use My Personal information
